{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:26:20Z","timestamp":1790745980834,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T00:00:00Z","timestamp":1648339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006678","name":"Association Fran\u00e7aise pour l'Etude du Foie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006678","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.molmet.2022.101483","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:33:59Z","timestamp":1648762439000},"page":"101483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Fibroblast growth factor 19 stimulates water intake"],"prefix":"10.1016","volume":"60","author":[{"given":"Jos\u00e9","family":"Ursic-Bedoya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Chavey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Desandr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iria","family":"Gonzalez-Dopeso Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Tordjmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ass\u00e9nat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5520-7311","authenticated-orcid":false,"given":"Urszula","family":"Hibner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1105-8115","authenticated-orcid":false,"given":"Damien","family":"Gregoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.molmet.2022.101483_bib1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cmet.2012.11.001","article-title":"Circulating fibroblast growth factors as metabolic regulators - a critical appraisal","volume":"16","author":"Angelin","year":"2012","journal-title":"Cell Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2022.101483_bib2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s42255-019-0074-3","article-title":"Metabolic Messengers: fibroblast growth factor 15\/19","volume":"1","author":"Gadaleta","year":"2019","journal-title":"Nature Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2022.101483_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2022.101483_bib4","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/hep.22771","article-title":"High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis","volume":"49","author":"Schaap","year":"2009","journal-title":"Hepatology"},{"issue":"March","key":"10.1016\/j.molmet.2022.101483_bib5","first-page":"1","article-title":"Expression of hepatic fibroblast growth factor 19 is enhanced in primary biliary cirrhosis and correlates with severity of the disease","volume":"5","author":"Wunsch","year":"2015","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/j.molmet.2022.101483_bib6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/hepr.13245","article-title":"CYP7A1 expression in hepatocytes is retained with upregulated fibroblast growth factor 19 in pediatric biliary atresia","volume":"49","author":"Hasegawa","year":"2019","journal-title":"Hepatology Research"},{"issue":"4","key":"10.1016\/j.molmet.2022.101483_bib7","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/me.2007-0313","article-title":"\u03b2klotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c","volume":"22","author":"Suzuki","year":"2008","journal-title":"Molecular Endocrinology"},{"issue":"8","key":"10.1016\/j.molmet.2022.101483_bib8","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1074\/jbc.M109.068783","article-title":"FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation","volume":"285","author":"Wu","year":"2010","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.molmet.2022.101483_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017868","article-title":"FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.molmet.2022.101483_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cmet.2017.09.005","article-title":"FGF19, FGF21, and an FGFR1\/\u03b2-klotho-activating antibody act on the nervous system to regulate body weight and glycemia","volume":"26","author":"Lan","year":"2017","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2022.101483_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms7980","article-title":"FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic-pituitary-adrenal axis","volume":"6","author":"Perry","year":"2015","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.molmet.2022.101483_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrd.2015.9","article-title":"Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23","volume":"15","author":"Degirolamo","year":"2016","journal-title":"Nature Reviews Drug Discovery"},{"issue":"10126","key":"10.1016\/j.molmet.2022.101483_bib13","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(18)30474-4","article-title":"NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"391","author":"Harrison","year":"2018","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.molmet.2022.101483_bib14","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/hep.30590","article-title":"NGM282 improves liver fibrosis and histology in 12 Weeks in patients with nonalcoholic steatohepatitis","volume":"71","author":"Harrison","year":"2020","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.molmet.2022.101483_bib15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/hep4.1209","article-title":"NGM 282 for treatment of patients with primary biliary cholangitis: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"2","author":"Mayo","year":"2018","journal-title":"Hepatology Communications"},{"issue":"3","key":"10.1016\/j.molmet.2022.101483_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2018.10.035","article-title":"Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: a multicenter, randomized, double-blind, placebo-controlled phase II trial","volume":"70","author":"Hirschfield","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2022.101483_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccr.2011.01.040","article-title":"Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by oncogenomic screening","volume":"19","author":"Sawey","year":"2011","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.molmet.2022.101483_bib18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/hep.26402","article-title":"Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma","volume":"58","author":"Wang","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2022.101483_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nature Genetics"},{"issue":"3","key":"10.1016\/j.molmet.2022.101483_bib20","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1053\/j.gastro.2019.05.001","article-title":"Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response","volume":"157","author":"Caruso","year":"2019","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.molmet.2022.101483_bib21","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1158\/2159-8290.CD-19-0367","article-title":"Acquired on-target clinical resistance validates fgfr4 as a driver of hepatocellular carcinoma","volume":"9","author":"Hatlen","year":"2019","journal-title":"Cancer Discovery"},{"issue":"1","key":"10.1016\/j.molmet.2022.101483_bib22","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1186\/s12885-019-6322-9","article-title":"Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma","volume":"19","author":"Maeda","year":"2019","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.molmet.2022.101483_bib23","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1158\/2159-8290.CD-19-0555","article-title":"First-in-human phase i study of fisogatinib (BLU-554) validates aberrant FGF19 signaling as a driver event in hepatocellular carcinoma","volume":"9","author":"Kim","year":"2019","journal-title":"Cancer Discovery"},{"issue":"10","key":"10.1016\/j.molmet.2022.101483_bib24","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1158\/1535-7163.MCT-18-0048","article-title":"Preclinical development of U3-1784, a novel FGFR4 antibody against cancer, and avoidance of its on-target toxicity","volume":"18","author":"Bartz","year":"2019","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.molmet.2022.101483_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2021.07.029","article-title":"Dark and bright side of targeting the fibroblast growth factor receptor 4 in the liver","author":"Gadaleta","year":"2021","journal-title":"Journal of Hepatology"},{"issue":"34","key":"10.1016\/j.molmet.2022.101483_bib26","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1073\/pnas.0907812106","article-title":"Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob\/ob mice","volume":"106","author":"Wu","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"15","key":"10.1016\/j.molmet.2022.101483_bib27","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1089\/hum.1997.8.15-1763","article-title":"Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers","volume":"8","author":"Zhang","year":"1997","journal-title":"Human Gene Therapy"},{"issue":"7","key":"10.1016\/j.molmet.2022.101483_bib28","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.gt.3300947","article-title":"Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA","volume":"6","author":"Liu","year":"1999","journal-title":"Gene Therapy"},{"issue":"2","key":"10.1016\/j.molmet.2022.101483_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cmet.2015.12.008","article-title":"FGF21 regulates sweet and alcohol preference","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2022.101483_bib30","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cmet.2018.04.001","article-title":"The hormone FGF21 stimulates water drinking in response to ketogenic diet and alcohol","volume":"27","author":"Song","year":"2018","journal-title":"Cell Metabolism"},{"issue":"2","key":"10.1016\/j.molmet.2022.101483_bib31","doi-asserted-by":"crossref","first-page":"100214","DOI":"10.1016\/j.jhepr.2020.100214","article-title":"TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload","volume":"3","author":"Bidault-Jourdainne","year":"2021","journal-title":"JHEP Reports"},{"issue":"10","key":"10.1016\/j.molmet.2022.101483_bib32","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.molmet.2022.101483_bib33","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1089\/10430349950017734","article-title":"High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA","volume":"10","author":"Zhang","year":"1999","journal-title":"Human Gene Therapy"},{"issue":"6","key":"10.1016\/j.molmet.2022.101483_bib34","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/en.2003-1671","article-title":"Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.molmet.2022.101483_bib35","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/endo.143.5.8850","article-title":"Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity","volume":"143","author":"Tomlinson","year":"2002","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.molmet.2022.101483_bib36","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nm.4363","article-title":"Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice","volume":"23","author":"Benoit","year":"2017","journal-title":"Nature Medicine"},{"issue":"6","key":"10.1016\/j.molmet.2022.101483_bib37","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jhep.2017.01.027","article-title":"Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19\/FGF15","volume":"66","author":"Zhou","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2022.101483_bib38","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0002-9440(10)61177-7","article-title":"A\u00a0mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice","volume":"160","author":"Nicholes","year":"2002","journal-title":"American Journal Of Pathology"},{"issue":"1","key":"10.1016\/j.molmet.2022.101483_bib39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0167-4781(98)00255-3","article-title":"Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain","volume":"1444","author":"Nishimura","year":"1999","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression"},{"issue":"9","key":"10.1016\/j.molmet.2022.101483_bib40","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1210\/en.2013-1191","article-title":"Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice","volume":"154","author":"Camporez","year":"2013","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.molmet.2022.101483_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202182","article-title":"FGF21 increases water intake, urine output and blood pressure in rats","volume":"13","author":"Turner","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.molmet.2022.101483_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molmet.2013.10.002","article-title":"Central action of FGF19 reduces hypothalamic AGRP\/NPY neuron activity and improves glucose metabolism","volume":"3","author":"Marcelin","year":"2014","journal-title":"Molecular Metabolism"},{"issue":"December 2017","key":"10.1016\/j.molmet.2022.101483_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmet.2017.12.003","article-title":"A\u00a0gut\u2013brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus","volume":"8","author":"Liu","year":"2018","journal-title":"Molecular Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2022.101483_bib44","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1073\/pnas.1323977111","article-title":"Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6","key":"10.1016\/j.molmet.2022.101483_bib45","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2796.2006.01731.x","article-title":"Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man","volume":"260","author":"Lund\u00e5sen","year":"2006","journal-title":"Journal of Internal Medicine"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877822000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877822000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:28:26Z","timestamp":1761956906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877822000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":45,"alternative-id":["S2212877822000527"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2022.101483","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast growth factor 19 stimulates water intake","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2022.101483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101483"}}